We recently launched our first-ever television advertising campaign, which offers a sense of the passion and compassion that defines how we care for people with cancer.

Pediatric Day Hospital Medical Director Farid Boulad explains that “we’re trying to excel at caring for the entire child, physically and emotionally.”

A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.

Michael was diagnosed with acute myelogenous leukemia at age 16. After receiving treatment in the Department of Pediatrics he is a cancer survivor and college student, looking forward to “taking the artistic field by force.”

In a large-scale genome-sequencing study, researchers have discovered mutations in neuroblastoma tumors that could aid the development of diagnostic tests and therapies.

Memorial Sloan-Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.